AATB is seeking nominations for the eight AATB councils in the following leadership positions: Chairperson, Vice-Chairperson, and Secretary.

AATB's legal counsel sent an email to the FDA Office of Chief Counsel requesting a meeting to discuss potential litigation against the FDA regarding its reclassification of human acellular dermal matrix (hADM) allografts for post-mastectomy breast reconstruction.

Blood Centers of America (BCA) and the American Association of Tissue Banks (AATB) have partnered to provide value to its accredited institutional members with aggregated purchasing power and critical supply management services. 

The Centers for Medicare & Medicaid Services have rescinded their February 23, 2022 mandate to broadly deny claims for “manipulated amniotic and/or placental tissue biologics for injections to treat illness.”

AATB submitted the below letter in response to the Centers for Medicare and Medicaid Services (CMS) Request for Information (RFI) on Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities.

In the ever-evolving supply chain world, supply continuity challenges keep business leaders awake at night

For industries to drive mission and individual organizational success, the future is unequivocal.

PHS guidance updates for organ donors regarding high-risk criteria have the potential to impact tissue criteria significantly.

Two NEW self-paced learning module programs are now available in the